RNU7-30P

Across TCGA pan-cancer cohorts, RNU7-30P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU7-30P data layer.

The strongest signal is observed in thymoma (THYM), where higher RNU7-30P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-30P expression acts as an unfavorable survival marker, although some lineages such as TGCT and OV show a favorable association.

THYM, MESO, and TGCT are the cancer types where RNU7-30P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	III,IV	0.103	0.944	<.001	57	view →
MESO	DFS	Tertile	III,IV	0.043	0.415	<.001	54	view →
TGCT	DFS	Tertile	All	1.000	0.758	.011	18	view →
LUAD	OS	Tertile	All	0.532	0.791	.045	9	view →
OV	DFS	Tertile	IV	0.666	0.408	.047	6	view →
STAD	DFS	Median	IV	0.162	0.437	.032	6	view →
ESCA	DFS	Tertile	III,IV	0.455	0.265	.038	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU7-30P–THYM (OS)

Open the THYM breakdown →